CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Debt to Equity Ratio : -0.2781 for Aug. 31, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2026 | -0.2781 |
| May 31, 2026 | -0.2486 |
| February 28, 2026 | -0.2611 |
| November 30, 2025 | -0.2277 |
| August 31, 2025 | -0.2744 |
| May 31, 2025 | -0.2847 |
| February 28, 2025 | -0.2938 |
| November 30, 2024 | -0.3215 |
| August 31, 2024 | -0.3423 |
| May 31, 2024 | -0.2576 |
| February 29, 2024 | -0.2554 |
| November 30, 2023 | -0.2908 |
| August 31, 2023 | -0.2865 |
| May 31, 2023 | -0.3247 |
| February 28, 2023 | -0.3408 |
| November 30, 2022 | -0.3227 |
| August 31, 2022 | -0.3961 |
| May 31, 2022 | -0.3898 |
| February 28, 2022 | -1.613 |
| November 30, 2021 | -3.512 |
| August 31, 2021 | -2.065 |
| May 31, 2021 | -3.02 |
| February 28, 2021 | -2.453 |
| November 30, 2020 | -7.816 |
| August 31, 2020 | 11.71 |
| Date | Value |
|---|---|
| May 31, 2020 | -6.190 |
| February 29, 2020 | -0.9409 |
| November 30, 2019 | -0.5944 |
| August 31, 2019 | -1.328 |
| May 31, 2019 | -0.9244 |
| February 28, 2019 | -1.232 |
| November 30, 2018 | -0.6941 |
| August 31, 2018 | -0.2563 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | -0.4216 |
| August 31, 2017 | -0.5378 |
| May 31, 2017 | -0.9596 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | -0.4455 |
| May 31, 2015 | -0.5874 |
| February 28, 2015 | -1.486 |
| November 30, 2014 | -1.980 |
| August 31, 2014 | 3.962 |
| May 31, 2014 | 0.5963 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.05M |
| Total Liabilities (Quarterly) | 117.13M |
| Shareholders Equity (Quarterly) | -98.07M |
| Current Ratio | 0.382 |
| Net Debt Paydown Yield | 0.00% |